References

Global cancer statistics, 2012

2015 · External reference

The American Joint Committee on Cancer: The 7th edition of the AJCC Cancer Staging Manual and the future of TNM

10.1245/s10434-010-0985-4 · 2010 · External reference

Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

10.1093/annonc/mdt240 · 2013 · External reference

EURECCA consensus conference highlights about rectal cancer clinical management: The radiation oncologist's expert review

10.1016/j.radonc.2013.10.024 · 2014 · External reference

Predictive biomarkers to chemoradiation in locally advanced rectal cancer

10.1155/2015/921435 · 2015 · External reference

Shotgun proteomics reveals specific modulated protein patterns in tears of patients with primary open angle glaucoma naive to therapy

10.1039/c3mb25463a · 2013 · External reference

Biomarkers for response to neoadjuvant chemoradiation for rectal cancer

10.1016/j.ijrobp.2009.03.003 · 2009 · External reference

Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD

2000 · External reference

Advances in lipidomics for cancer biomarkers discovery

10.3390/ijms17121992 · 2016 · External reference

Osteoblast-derived sphingosine 1-phosphate to induce proliferation and confer resistance to therapeutics to bone metastasis-derived prostate cancer cells

10.1016/j.molonc.2014.04.001 · 2014 · External reference

Bioactive lipids s1p and c1p are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy

10.1158/1541-7786.mcr-12-0600 · 2013 · External reference

Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy

10.1158/1541-7786.mcr-14-0188 · 2014 · External reference

Molecular mechanisms of target recognition by lipid gpcrs: Relevance for cancer

2014 · External reference

Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest

10.1158/1078-0432.ccr-05-0879 · 2005 · External reference

Hpebp4 resists trail-induced apoptosis of human prostate cancer cells by activating akt and deactivating erk1/2 pathways

10.1074/jbc.m609494200 · 2007 · External reference

Anti-apoptotic hpebp4 silencing promotes trail-induced apoptosis of human ovarian cancer cells by activating ERK and JNK pathways

2006 · External reference

Human phosphatidylethanolamine-binding protein 4 promoted the radioresistance of human rectal cancer by activating akt in an ROS-dependent way

10.1371/journal.pone.0090062 · 2014 · External reference

Hpebp4 as a predictive marker for the pathological response of rectal cancer to preoperative radiotherapy

10.1007/s00384-012-1534-3 · 2013 · External reference

Choline metabolism in malignant transformation

10.1038/nrc3162 · 2011 · External reference

Plasma lysophosphatidylcholine levels: Potential biomarkers for colorectal cancer

10.1200/jco.2006.08.5571 · 2007 · External reference

Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases

10.1016/j.chemphyslip.2015.07.008 · 2016 · External reference

Biologically active sphingolipids in cancer pathogenesis and treatment

10.1038/nrc1411 · 2004 · External reference

Many ceramides

10.1074/jbc.r111.254359 · 2011 · External reference